Cerebrospinal fluid (β2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment

B. Brew,R. Bhalla,M. Paul,J. Sidtis,J. Keilp,Abigail E. Sadler,H. Gallardo,J. McArthur,M. Schwartz,R. Price
DOI: https://doi.org/10.1097/00002030-199205000-00004
1992-05-01
Abstract:ConclusionsCSF (β2M may be a valuable marker of ADC severity and response to antiviral therapy.
What problem does this paper attempt to address?